Skip to main content
logo
Sharp Therapeutics Corp. (TSXV:SHRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.9100
-0.0900 (-9.00%)
At close: Jun 30, 2026

Sharp Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-6.17-3.26-3.56-3.88
Depreciation & Amortization
0.10.10.110.13
Stock-Based Compensation
0.250.010.030.08
Other Operating Activities
0.69-0.531.31.47
Change in Accounts Payable
0.320.050.180.16
Change in Other Net Operating Assets
-0.020.01-0.020
Operating Cash Flow
-4.83-3.62-1.96-2.05
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
--0.01-0.01-
Other Investing Activities
-0.01--
Investing Cash Flow
--0.01-0.01-

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
-2.2--
Short-Term Debt Repaid
--0.24--
Long-Term Debt Repaid
-0.2-0.2-0.2-0.18
Total Debt Repaid
-0.2-0.44-0.2-0.18
Net Debt Issued (Repaid)
-0.21.76-0.2-0.18
Issuance of Common Stock
2.524.962.381.2
Financing Cash Flow
2.326.732.181.02

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-0.020.01--
Net Cash Flow
-2.533.110.21-1.03

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-4.83-3.63-1.97-2.05
Free Cash Flow Growth
----
Free Cash Flow Per Share
-0.16-0.40-0.45-14.77
Levered Free Cash Flow
-3.03-1.34-1.23-
Unlevered Free Cash Flow
-2.93-1.24-1.12-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
0.30.060.160.16